Novel anti-cancer drugs - Novel anti-cancer drugsNovel anti-cancer drugsNovel anti-cancer drugs

  • Telphone : 123456789
  • Email Address: info@labtechco.com
CONSULTATION
  • Home
  • About Us
    • Leadership
    • R&D center
    • Partnerships
  • Our Product
    • Features
    • Approach
    • Pipeline
  • Our Science
    • Mechanism
    • Publications
  • News & Media
    • New updates
    • Press release
  • Investors Resources
    • General Info
    • Corporate Governance
    • Financial Statements
  • Contacts

New Updates

New Updates

Companion Animal Treatment Performance C...

Gongwinbiopharm granted for MUMS sponsor...

Canine Melanoma Field Trial Approved by ...

Canine Melanoma Field Trial Approved by ...

PTS302 receives Official Market Approval...

BIO One-on-One Partnering™

Gongwin Biopharm Holdings, Co., Ltd. Cayman (Gongwin-KY; ticker: 6617) founded in 2014 is a Taiwan based clinical stage biopharmaceutical company focused on developing novel anti-cancer drugs.

USEFUL LINKS

  • About Us
  • Pipeline
  • Leadership
  • Contacts
  • Research

OUR SERVICES

  • Scientific
  • Chemistry
  • Gemological
  • Forensic science
  • Immunology

Address

3F., No.80, Sec. 1, Jianguo N. Rd., Zhongshan Dist., Taipei City 104, Taiwan (R.O.C.)

Copyright © 2026 Gongwinbiopharm. All rights reserved.